Adaptimmune Therapeutics PLC Annual Share-based Payment Arrangement, Expense in USD from 2013 to 2024

Taxonomy & unit
us-gaap: USD
Description
Amount of expense for award under share-based payment arrangement. Excludes amount capitalized.
Summary
Adaptimmune Therapeutics PLC quarterly/annual Share-based Payment Arrangement, Expense history and growth rate from 2013 to 2024.
  • Adaptimmune Therapeutics PLC Share-based Payment Arrangement, Expense for the quarter ending December 31, 2024 was $2.84M, a 7.77% decline year-over-year.
  • Adaptimmune Therapeutics PLC Share-based Payment Arrangement, Expense for the twelve months ending December 31, 2024 was $12.1M, a 2.36% increase year-over-year.
  • Adaptimmune Therapeutics PLC annual Share-based Payment Arrangement, Expense for 2024 was $12.1M, a 2.36% increase from 2023.
  • Adaptimmune Therapeutics PLC annual Share-based Payment Arrangement, Expense for 2023 was $11.8M, a 35.5% decline from 2022.
  • Adaptimmune Therapeutics PLC annual Share-based Payment Arrangement, Expense for 2022 was $18.2M, a 11.6% decline from 2021.
Share-based Payment Arrangement, Expense, Trailing 12 Months (USD)
Share-based Payment Arrangement, Expense, Annual (USD)
Share-based Payment Arrangement, Expense, YoY Annual Growth (%)
Period Value YoY Chg Change % Start Date End Date Report Filed
2024 $12.1M +$278K +2.36% Jan 1, 2024 Dec 31, 2024 10-K 2025-03-24
2023 $11.8M -$6.47M -35.5% Jan 1, 2023 Dec 31, 2023 10-K 2025-03-24
2022 $18.2M -$2.39M -11.6% Jan 1, 2022 Dec 31, 2022 10-K 2025-03-24
2021 $20.6M +$10.2M +98.1% Jan 1, 2021 Dec 31, 2021 10-K 2024-03-06
2020 $10.4M -$639K -5.78% Jan 1, 2020 Dec 31, 2020 10-K 2023-03-06
2019 $11.1M -$5.15M -31.8% Jan 1, 2019 Dec 31, 2019 10-K 2021-02-25
2018 $16.2M +$5.4M +50% Jan 1, 2018 Dec 31, 2018 10-K 2021-02-25
2017 $10.8M +$1.98M +22.5% Jan 1, 2017 Dec 31, 2017 10-K 2019-02-27
2016 $8.82M +$1.74M +24.6% Jan 1, 2016 Dec 31, 2016 10-K 2019-02-27
2015 $7.08M +$6.75M +2032% Jul 1, 2014 Jun 30, 2015 10-K 2018-03-15
2014 $332K +$154K +86.5% Jul 1, 2013 Jun 30, 2014 10-K 2017-03-13
2013 $178K Jul 1, 2012 Jun 30, 2013 8-K 2016-07-08
* An asterisk sign (*) next to the value indicates that the value is likely invalid.